Extracorporeal photopheresis in chronic graft-versus-host disease. - Wikidata - wikimedia - TriplyDB

Extracorporeal photopheresis in chronic graft-versus-host disease.

Extracorporeal photopheresis in chronic graft-versus-host disease.

http://www.wikidata.org/entity/Q34662907

about

Efficacy of extracorporeal photopheresis in clearance of antibodies to donor-specific and lung-specific antigens in lung transplant recipients.Extracorporeal photopheresis combined with pentostatin in the conditioning regimen for canine hematopoietic cell transplantation does not prevent GVHD.Extracorporeal Photochemotherapy as a Challenging Treatment for Cutaneous T-Cell Lymphoma, Acute and Chronic Graft-versus-Host Disease, Organ Rejection and T-Lymphocyte-Mediated Autoimmune Diseases.Extracorporeal photopheresis in addition to pentostatin in conditioning for canine hematopoietic cell transplantation: role in engraftment.Emerging therapies for graft-versus-host disease.Mechanism of action of extracorporeal photochemotherapy in chronic graft-versus-host disease.Extracorporeal photopheresis in graft-versus-host disease.Extracorporeal photopheresis in the treatment of graft-versus-host disease: evidence and opinion Extracorporeal photopheresis, a therapeutic option for cutaneous T-cell lymphoma and immunological diseases: state of the art.Extracorporeal photopheresis after heart transplantation.Current clinical applications of extracorporeal photochemotherapy.Extracorporeal photopheresis as a therapy for autoimmune diseases.Pyrrolo[3,2-h]quinazolines as photochemotherapeutic agents.Previously Activated Psoralen: A Possible Novel Format of Psoralen Used in the Treatment of Graft-versus-host Disease.Extracorporeal photopheresis: Review of technical aspects Treating refractory chronic graft-versus-host disease with extracorporeal photochemotherapy.Investigation of heparin-related hypotensive adverse events during photopheresis: utility of a patient care database.CD4+CD25+ lymphocyte subsets in chronic graft versus host disease patients undergoing extracorporeal photochemotherapy.Integrin-driven monocyte to dendritic cell conversion in modified extracorporeal photochemotherapy.Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors.

P2860

Q34036197-C07F3125-DFFE-4C02-BCF3-C569AD512108 Q34135339-D9E54A65-1DA7-4FC0-91D1-178F68D96824 Q34870346-E7A69A39-8A35-4349-A51F-C6FBBF61BB42 Q35050513-649FD8CC-6FE1-4915-B7DD-D73FE53062BC Q35602633-7BF2C14F-7C8B-41DA-8548-80FFC859854E Q35815967-D47FE2C9-760D-4BBA-8875-687C47891F47 Q37051405-150339EA-8E73-4126-8337-3FD5966C908D Q37154179-97192CA9-FF90-4BCB-AEA1-90BDE37550BD Q38010239-D841D701-97C7-45EA-AB7C-2232644E1C0B Q38260052-8CFC4F65-F694-41CF-BB37-71889A1046BB Q38264394-54E48F1D-A0ED-4E6C-B16B-F8CB8CF9CD5B Q38302612-7F4B2915-48F2-42DC-8282-22879805FDE9 Q39541968-E86AF60B-EB8B-43C1-94CA-5B59CDF41341 Q41469646-62724C92-A90D-4DAD-842A-28AD8E16B592 Q41953441-3F6AF0C1-E214-4BC3-AE2F-6C2009D2F920 Q44351269-DB88E8D4-B023-42BB-8E87-C8E95A3A942C Q44961513-19B75208-EE1D-4F99-B305-6A0C8568A53C Q46819530-EF285B59-57BD-4394-B8BA-F5E56A363797 Q53677640-A5099733-C14F-49D8-AC99-4805FB5A8617 Q53859811-7950112E-0FF9-4BBD-AF42-8E448AFE0AF6

P2860

Extracorporeal photopheresis in chronic graft-versus-host disease.

http://www.wikidata.org/entity/Q34662907

description

2002 nî lūn-bûn

@nan

2002 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Extracorporeal photopheresis in chronic graft-versus-host disease.

@ast

Extracorporeal photopheresis in chronic graft-versus-host disease.

@en

Extracorporeal photopheresis in chronic graft-versus-host disease.

@nl

type

label

Extracorporeal photopheresis in chronic graft-versus-host disease.

@ast

Extracorporeal photopheresis in chronic graft-versus-host disease.

@en

Extracorporeal photopheresis in chronic graft-versus-host disease.

@nl

prefLabel

Extracorporeal photopheresis in chronic graft-versus-host disease.

@ast

Extracorporeal photopheresis in chronic graft-versus-host disease.

@en

Extracorporeal photopheresis in chronic graft-versus-host disease.

@nl

P1433

Q34662907-B02BBC07-D4FB-4C7A-9FB1-C7107A07A3EE

P1476

Q34662907-77C8287E-241A-4CA4-8AF7-A743EECD143A

P2093

Q34662907-A6781F41-EAEA-4681-A1F6-F03B8E0C5032

Q34662907-C561F2EF-7439-4BDB-84C0-DBC47C6555BE

Q34662907-E8731B8E-1D10-45A1-9F52-2202DD1F01F8

P2860

Q34662907-066EAECA-4A88-45D7-A28C-5B313619093B

Q34662907-169562AB-5180-4DA8-84ED-94AD7DE41F98

Q34662907-1B8475BA-ABB2-4A34-93A0-6E2DF096EBFA

Q34662907-1D51EBD5-0519-4C51-B4E7-13E2CB3BDEBF

Q34662907-24961659-A4F6-411B-82E2-ACF5135954E9

Q34662907-33B6F2F3-2663-418D-BFF0-142B1CCFC3CD

Q34662907-39F3FA40-F2BA-4735-9E6F-B7D00F8E20E3

Q34662907-4AD09B84-DEAF-419A-8071-10E147224F22

Q34662907-4E33F450-3638-4744-A217-3D1C57EDB187

Q34662907-5B997AF1-4380-4979-A440-D66F9ACE078A

P2888

Q34662907-EA3C9831-DAC2-4B4B-8DC0-CD078447830F

P304

Q34662907-725D38F6-1DCB-4E78-8CE3-0F7E9D9AA56B

P31

Q34662907-48D5C01C-BAFB-4D9F-A6FD-BF095129D612

P356

Q34662907-5137B7E7-3ACA-4A8D-B9DA-B2664B0D59A3

P407

Q34662907-8F4ED3F9-991B-4E0D-BD3F-80CF8513DCF2

P433

Q34662907-0617E278-FF92-4BC8-A697-8954573F0D0F

P478

Q34662907-5154641A-BB22-4500-8A02-B59C73D079E5

P577

Q34662907-79F625E8-B55A-48E5-8720-6E3C074F6C07

P5875

Q34662907-15F2435D-58B6-4D93-AA36-2F44CA54CCF1

P6179

Q34662907-CCB31169-7F11-4B40-A1E9-4C1E344DF3D0

P698

Q34662907-FC5B6588-9F1B-4A98-8079-883C86A90B63

P356

P1433

Bone Marrow Transplantation

P1476

Extracorporeal photopheresis in chronic graft-versus-host disease.

@en

P2093

Foss FM

http://www.w3.org/2001/XMLSchema#string

Gorgun G

http://www.w3.org/2001/XMLSchema#string

Miller KB

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results

Prevention of lethal acute graft-versus-host disease in mice by oral administration of T helper 1 inhibitor, TAK-603.

Photopheresis: clinical applications and mechanism of action.

Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft rejection: considerations for the allogeneic transplantation therapy of leukemia and lymphoma.

Drug therapy for acute graft-versus-host disease prophylaxis.

How I treat chronic graft-versus-host disease.

New immunosuppressants in BMT/GVHD.

Chronic graft-versus-host disease: clinical manifestation and therapy.

The inhibition of antigen-presenting activity of dendritic cells resulting from UV irradiation of murine skin is restored by in vitro photorepair of cyclobutane pyrimidine dimers.

Photopheresis: a clinically relevant immunobiologic response modifier.

P2888

P304

719-725

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BMT.1703529

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2002-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11333558

http://www.w3.org/2001/XMLSchema#string

P6179

1029453442

http://www.w3.org/2001/XMLSchema#string

P698

12040467

http://www.w3.org/2001/XMLSchema#string